Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants

被引:1
|
作者
Liu, Chang [1 ,2 ,3 ,4 ]
Shi, Yuan [1 ,2 ,3 ,4 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing 400014, Peoples R China
[2] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing 400014, Peoples R China
[3] Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China
[4] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China
关键词
patent ductus arteriosus; fluid balance; ibuprofen; preterm infants; BRONCHOPULMONARY DYSPLASIA; GROWTH VELOCITY; RISK-FACTORS; RESTRICTION; CLOSURE; LIFE; PREDICTORS; MANAGEMENT;
D O I
10.31083/j.rcm2403078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Excessive fluid intake is a predictor of the development of patent ductus arteriosus (PDA) in preterm infants. Previous studies have examined the relationship between fluid intake and outcomes following ibuprofen for PDA. However, there is a lack of data to determine whether fluid balance has an effect on ibuprofen treatment for PDA. Therefore, this study sought to determine the relationship between fluid balance and outcomes following treatment with ibuprofen for PDA. Methods: We conducted a retrospective study of 110 infants admitted to the Children's Hospital of Chongqing Medical University between January 2017 and April 2022, who were treated with ibuprofen for hemodynamically significant PDA (hsPDA). We calculated the average fluid balance before and during the two courses of ibuprofen treatment and whether they were significantly associated with outcomes in hsPDA patients. Results: In the first course of ibuprofen treatment (FIT), responders had lower fluid balance before FIT compared to non-responders [median 31.82 (18.01, 39.66) vs 34.68 (25.31, 43.56) mL/kg/day; p = 0.049], while the fluid balance during FIT [median 40.61 (33.18, 63.06) vs 42.65 (30.02, 57.96) mL/kg/day; p = 0.703] did not differ between responders and non-responders. Fluid balance before the second course of ibuprofen treatment (SIT) (mean 41.58 +/- 14.26 vs 35.74 +/- 10.99 mL/kg/day; p = 0.322) and during SIT (mean 39.21 +/- 12.65 vs 37.00 +/- 21.38 mL/kg/day; p = 0.813) was not found to have a significant association with SIT outcome. Multivariate logistic regression analysis showed fluid balance before FIT was a predictor for FIT success [Odds ratio (OR): 0.967; 95% confidence interval (CI): 0.935-0.999; p = 0.042]. Fluid balance within the first week of life had a greater association with the FIT outcome (OR: 0.967, 95% CI: 0.939-0.996, p = 0.027). Gestational diabetes mellitus and higher Apgar scores decreased the possibility of PDA closure after FIT. Conclusions: Lower fluid balance before FIT, especially within the first week of life appeared to be a predictor for closure of hsPDA after FIT in preterm infants.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants
    Maria Pia De Carolis
    Constantino Romagnoli
    Valentina Polimeni
    Fiammetta Piersigilli
    Enrico Zecca
    Patrizia Papacci
    Angelica Bibiana Delogu
    Giuseppe Tortorolo
    European Journal of Pediatrics, 2000, 159 : 364 - 368
  • [22] Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus
    R. Antonucci
    L. Cuzzolin
    A. Arceri
    A. Dessì
    V. Fanos
    European Journal of Clinical Pharmacology, 2009, 65 : 223 - 230
  • [23] Ibuprofen treatment after the first days of life in preterm neonates with patent ductus arteriosus
    de Klerk, Johan C. A.
    van Paassen, Nanda
    van Beynum, Ingrid M.
    Flint, Robert B.
    Reiss, Irwin K. M.
    Simons, Sinno H. P.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (15) : 2411 - 2417
  • [24] Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
    Dani, Carlo
    Lista, Gianluca
    Bianchi, Silvia
    Mosca, Fabio
    Schena, Federico
    Ramenghi, Luca
    Zecca, Enrico
    Vento, Giovanni
    Poggi, Chiara
    Leonardi, Valentina
    Minghetti, Diego
    Rosignoli, Maria Teresa
    Calisti, Fabrizio
    Comandini, Alessandro
    Cattaneo, Agnese
    Lipone, Paola
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (03) : 807 - 816
  • [25] Paracetamol treatment of patent ductus arteriosus in preterm infants
    Nadir, E.
    Kassem, E.
    Foldi, S.
    Hochberg, A.
    Feldman, M.
    JOURNAL OF PERINATOLOGY, 2014, 34 (10) : 748 - 749
  • [26] Patent Ductus Arteriosus in Preterm Infants
    Chen, Jia-Yuh
    PEDIATRICS AND NEONATOLOGY, 2012, 53 (05) : 275 - 275
  • [27] Patent Ductus Arteriosus in Preterm Infants
    Sasi, Arun
    Deorari, Ashok
    INDIAN PEDIATRICS, 2011, 48 (04) : 301 - 308
  • [28] Patent ductus arteriosus in preterm infants
    Arun Sasi
    Ashok Deorari
    Indian Pediatrics, 2011, 48 : 301 - 308
  • [29] Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada
    Lokku, Armend
    Mirea, Lucia
    Lee, Shoo K.
    Shah, Prakeshkumar S.
    AMERICAN JOURNAL OF PERINATOLOGY, 2017, 34 (05) : 441 - 450
  • [30] Prolonged treatment of patent ductus arteriosus with paracetamol in very low birth weight preterm infants
    Silva, Scarlet Cotua
    Molina, Aldo Bancalari
    Seguel, Macarena Sandoval
    ANDES PEDIATRICA, 2024, 95 (05): : 573 - 582